SGLT-2 inhibitors in Heart Failure
SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the management of HFrEF or heart failure. Lets discover what makes them special drugs in heart failure.
~-~~-~~~-~~-~
Please watch: "ADAPTABLE trial. Aspirin dose for secondary prevention. "
• ADAPTABLE trial. Aspir...
~-~~-~~~-~~-~
Пікірлер: 11
SGLT2 inhibitor Jardiance truly works and reduced blood sugar to desired levels and have no serious side effects. It is a good invention.
Terrific info. My life totally changer after being prescribed Forxiga. I would be thrilled to spread the word that heart failure symptoms can be reduced.
@westfield90
11 ай бұрын
Can I ask what dose of FARXIGA do you take? Also how soon after taking it did not notice improvement and finally did it improve your ejection fraction? Thank you
Thank You for this information!
Sound on this video is horrible! Impossible for me to hear with booming background sound!
This is the Channel i was always looking for!!!! So happy and Greetings From Germany
@CardioEd
2 жыл бұрын
Thank you buddy.
Excellent
💗💗💗💗
Question: Are SGLT2 inhibitors suitable for someone with HF and late stage 3 CKD with metabolic acidosis while on insulin therapy?
@kathywatt7555
11 ай бұрын
Why not try? I could barely get out of bed. My BNP is now normal. I can walk again.